| Janssen-Cilag AG - Lazcluze 240 mg, Filmtabletten | | 69751 | | 02 | | Lazcluze 240 mg | | Filmtabletten | | | | | | 07.02.2025 | | |
| | Composition | | lazertinibum 240 mg ut lazertinibi mesilas monohydricus 289.44 mg, silica hydrophobica colloidalis, cellulosum microcristallinum, mannitolum, carmellosum natricum conexum corresp. natrium max. 2.4 mg, magnesii stearas, Überzug: copolymerum macrogolo et alcoholi poly(vinylico) constatum, talcum, E 171, glyceroli monocaprylocapras, poly(alcohol vinylicus), E 172 (rubrum), E 172 (nigrum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Lazertinibum | 240 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Nigrum) | | | | (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | Copolymerum Macrogolo et Alcoholi Poly(Vinylico) Constatum | | Überzug | | E 171 | | color. | | E 172 | | color. | | Glyceroli Monocaprylocapras | | | | Magnesii Stearas | | | | Mannitol | | | | Poly(Alcohol Vinylicus) | | | | Pro Compresso Obducto | | | | Silica Hydrophobica Colloidalis | | | | Talcum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 28 | DDP | DDP | A | | Non |
|
|
